dc.description.abstract |
Introduction: Human leukocyte antigens (HLA) play a central role in the cellular and humoral
immune responses that determine the outcome of a transplant. The extensive polymorphism of HLA
poses a major barrier to successful transplantation.
Blood groups refer not only to genetically encoded erythrocyte antigens but also the immunologic
diversity expressed by other blood constituents, including leukocytes, platelets, and plasma. The ABO
blood group system has the single most important blood group antigens. Kidney donors must have a
compatible blood type with the recipient for the transplant to be accepted by the recipient’s organism
and immune system.
Aim:To evaluate kidney recipients’ HLA allele frequencies among patients with different blood
groups.
Objective:
1. To determine the most frequent HLA – A, HLA – B, HLA – DR alleles among kidney
recipients.
2. To compare HLA – A allele frequencies among kidney recipients with different blood groups.
3. To compare HLA – B allele frequencies among kidney recipients with different blood groups.
4. To compare HLA – DR allele frequencies among kidney recipients with different blood
groups.
Methods: The retrospective data analysis of patients who were in the waitlist for kidney
transplant in Hospital Lithuanian University of Health Sciences Kaunas Clinics during years 2013 –
2014 was performed. The following data was analyzed: ABO blood group antigens detected using
column agglutination technique and class I (HLA – A, HLA – B), class II (HLA – DR) HLA antigens,
detected using either lymphocytotoxic or molecular biology method. Data analysis was performed using
Microsoft Excel and SPSS 19.0 software package. To assess the significance of the results the method
of chi-square (X2) was used, assuming the results to be statistically significant with p<0,05.
Results: The study included 250 LUHS Kaunas clinics patients waiting for kidney transplant.
The most frequent (rate >8%) HLA-A, HLA-B, HLA-DR alleles were determined. The most frequent
of the HLA-A alleles were 1 (8.8%), 2 (30.8%), 3 (16%), 11 (8%). Among HLA-B, the most frequent
were 7 (28%), 8 (10.8%), 13 (10%). And among HLA-DR alleles: 1 (15%), 4 (12%), 7 (13.2%), 8 (8%)
and 15 (8.8%). HLA-A 11 allele presence among different blood groups was statistically significant (p
= 0.008); 36 out of 250 patients had this allele, it was detected in different blood groups in the following
frequencies: O (n = 11; 32.4%), A (n = 8; 23.5%), B (n = 10; 29.4%), AB (n = 5, 14.7%). HLA-B 7
allele presence among different blood groups was statistically significant (p = 0.042), 65 out of 250
patients had this allele, it was detected in different blood groups in the following frequencies: O (n = 26;
43.3%), A (n = 22; 36.7%), B (n = 9; 15.0%), AB (n = 3; 5%). HLA-DR 8 allele presence among different
blood groups was statistically significant (p = 0.028); 33 out of 250 patients had this allele, it was
detected in different blood groups in the following frequencies: O (n = 11; 34.4%), A (n = 10; 31.3% ),
B (n = 5, 15.6%), AB (n = 6; 18.78%).The presence of other HLA-A (1, 2, 3), HLA-B (8; 13) and HLADR
(1; 4; 7; 15) alleles in blood groups was not statistically significant, p> 0.05.
Conclusions: 1. 1. The most frequently observed alleles were the following: HLA–A: 1, 2, 3,
11: HLA–B: 7, 8, 13; HLA–DR: 1, 4, 7, 8, 15.
2. HLA–A 11 allele dominated between kidney recipients with O and B blood groups.
3. HLA–B 7 allele dominated between kidney recipients with O and A blood groups.
4. HLA–DR 8 allele dominated between kidney recipients with O and A blood groups.
Keywords: HLA-A, HLA-B, HLA-DR. |
en_US |